Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Bostwick

Showing results (191-200 of 317) with videos related to

Pageof 32
Sort By:
The Journal of Urology|March 19, 1999
Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgeryS D Sweat, A Pacelli, E J Bergstralh, et al.
Human Pathology|May 23, 2000
10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancerM A Rubin, A Gerstein, K Reid, et al.
Urology|August 1, 1996
Transurethral enzymatic ablation of the prostate: canine modelW J Harmon, D M Barrett, J Qian, et al.
Cancer|March 30, 2000
Cancer heterogeneity and its biologic implications in the grading of urothelial carcinomaL Cheng, R M Neumann, A Nehra, et al.
Cancer|July 15, 1996
Origins of prostate cancerR Montironi, D G Bostwick, H Bonkhoff, et al.
The New England Journal of Medicine|December 3, 1987
Expression of opioid peptides in tumorsD G Bostwick, W E Null, D Holmes, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
When is intervention warranted?R D Williams, D G Bostwick, C W Boone, et al.
Clinical Transplantation|October 1, 1993
Diagnosis of hepatic allograft rejection: role of liver biopsyP P Aran, M G Bissel, P F Whitington, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimensT M Pisansky, M L Blute, V J Suman, et al.
Urology|September 4, 1999
Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinomaM T Gettman, A Pacelli, J Slezak, et al.
Pageof 32

Showing results (191-200 of 317) with videos related to

Sort By:
Pageof 32
The Journal of Urology|March 19, 1999
Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgeryS D Sweat, A Pacelli, E J Bergstralh, et al.
Human Pathology|May 23, 2000
10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancerM A Rubin, A Gerstein, K Reid, et al.
Urology|August 1, 1996
Transurethral enzymatic ablation of the prostate: canine modelW J Harmon, D M Barrett, J Qian, et al.
Cancer|March 30, 2000
Cancer heterogeneity and its biologic implications in the grading of urothelial carcinomaL Cheng, R M Neumann, A Nehra, et al.
Cancer|July 15, 1996
Origins of prostate cancerR Montironi, D G Bostwick, H Bonkhoff, et al.
The New England Journal of Medicine|December 3, 1987
Expression of opioid peptides in tumorsD G Bostwick, W E Null, D Holmes, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
When is intervention warranted?R D Williams, D G Bostwick, C W Boone, et al.
Clinical Transplantation|October 1, 1993
Diagnosis of hepatic allograft rejection: role of liver biopsyP P Aran, M G Bissel, P F Whitington, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimensT M Pisansky, M L Blute, V J Suman, et al.
Urology|September 4, 1999
Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinomaM T Gettman, A Pacelli, J Slezak, et al.
Pageof 32